Takeda Held Responsible in First Federal Actos Bellwether Trial

After 34 days of trial, a Lafayette, Louisiana jury returned its verdict against Takeda and Lilly and ordered the PHARMA giants to pay $1.475 million in compensatory damages and $8 billion in punitive damages for injuries including bladder cancer to Terrance Allen, a hardware store manager, who took Actos for his diabetes treatment from 2004 [...]

April 8th, 2014|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Takeda Held Responsible in First Federal Actos Bellwether Trial

Takeda’s Future after Losing Actos Patent

In 2012, Takeda’s profit dropped 53% and net profit was down 14% in the last nine months of 2012. Why? Because medical studies have demonstrated the causal connection between Takeda’s flagship diabetes drug Actos and bladder cancer and Takeda also lost its exclusivity patent on its foundation product diabetes treatment.  Actos accounted for more than [...]

August 26th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Takeda’s Future after Losing Actos Patent